Skip to main content
. 2022 Jan 5;26(4):1060–1070. doi: 10.1111/jcmm.17158

FIGURE 3.

FIGURE 3

Attenuation of pathologic damage in GVHD target organs treated by berberine (N = 10/group). (A–C) Histology of lung in each group (100×). (D–F) Histology of liver in each group (400×). (G–I) Histology of colon in each group (400×). (J) The pathology score of the lung, liver and colon in three groups using SSS as detailed in Methods section. Data are shown as mean ± SD and were analysed by one‐way ANOVA. * p < 0.05 and ** p < 0.01